ONCY
Oncolytics Biotech
ONCY
ONCY
42 hedge funds and large institutions have $700K invested in Oncolytics Biotech in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$101K | |
| 2 | +$70K | |
| 3 | +$34K | |
| 4 |
Morgan Stanley
New York
|
+$32.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$21K |
Top Sellers
| 1 | -$18K | |
| 2 | -$13.3K | |
| 3 | -$11.5K | |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$10K |
| 5 |
ZB
Zions Bancorporation
Salt Lake City,
Utah
|
-$8K |